Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PLA2 Inhibitor Varespladib as an Alternative to the Antivenom Treatment for Bites from Nikolsky’s Viper Vipera berus nikolskii
Олександр Зіненко, Igor Tovstukha, Yevgen Korniyenko
Toxins (2020) Vol. 12, Iss. 6, pp. 356-356
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Haemotoxicity of snakes: a review of pathogenesis, clinical manifestations, novel diagnostics and challenges in management
Bhawani Yasassri Alvitigala, Harsha Dissanayake, Praveen Weeratunga, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene (2025)
Open Access | Times Cited: 2
Varespladib in the Treatment of Snakebite Envenoming: Development History and Preclinical Evidence Supporting Advancement to Clinical Trials in Patients Bitten by Venomous Snakes
Matthew R. Lewin, Rebecca W. Carter, Isabel A. Matteo, et al.
Toxins (2022) Vol. 14, Iss. 11, pp. 783-783
Open Access | Times Cited: 47
Viper Venom Phospholipase A2 Database: The Structural and Functional Anatomy of a Primary Toxin in Envenomation
Ana Oliveira, Miguel T. Lacerda, Maria J. Ramos, et al.
Toxins (2024) Vol. 16, Iss. 2, pp. 71-71
Open Access | Times Cited: 10
Feasibility Study: Varespladib protects rodents from lethal doses of whole bee (Apis mellifera) venom.
James Hearth, Kaitlin Linne, Jerry Harrison, et al.
Toxicon X (2025) Vol. 25, pp. 100214-100214
Open Access | Times Cited: 1
Snake venom protection by a cocktail of varespladib and broadly neutralizing human antibodies
Jacob Glanville, Mark Bellin, S. Pletnev, et al.
Cell (2025)
Closed Access | Times Cited: 1
Unraveling snake venom phospholipase A2: an overview of its structure, pharmacology, and inhibitors
Ganesh H. Sampat, Kashinath Hiremath, Jagadeesh Dodakallanavar, et al.
Pharmacological Reports (2023) Vol. 75, Iss. 6, pp. 1454-1473
Closed Access | Times Cited: 14
Cerebral Complications of Snakebite Envenoming: Case Studies
Yu-Kai Huang, Yen-Chia Chen, Chia-Chun Liu, et al.
Toxins (2022) Vol. 14, Iss. 7, pp. 436-436
Open Access | Times Cited: 19
The synthetic varespladib molecule is a multi-functional inhibitor for PLA2 and PLA2-like ophidic toxins
Daniela P. Marchi‐Salvador, Rafael J. Borges, Bruno Lomonte, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2021) Vol. 1865, Iss. 7, pp. 129913-129913
Closed Access | Times Cited: 26
Venom-Induced Blood Disturbances by Palearctic Viperid Snakes, and Their Relative Neutralization by Antivenoms and Enzyme-Inhibitors
Abhinandan Chowdhury, Christina N. Zdenek, Matthew R. Lewin, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 26
Anticoagulant Activity of Naja nigricollis Venom Is Mediated by Phospholipase A2 Toxins and Inhibited by Varespladib
Taline D. Kazandjian, Arif Arrahman, Kristina B. M. Still, et al.
Toxins (2021) Vol. 13, Iss. 5, pp. 302-302
Open Access | Times Cited: 24
Effects of the Heterodimeric Neurotoxic Phospholipase A2 from the Venom of Vipera nikolskii on the Contractility of Rat Papillary Muscles and Thoracic Aortas
А. С. Аверин, Vladislav G. Starkov, Victor I. Tsetlin, et al.
Toxins (2024) Vol. 16, Iss. 2, pp. 100-100
Open Access | Times Cited: 3
Enhancing Snakebite Management: The Role of Small Molecule Therapeutics in Complementing Antivenom Strategies
Grasiela Mariano Silva, Abhinandan Chowdhury
Toxicon (2024) Vol. 249, pp. 108081-108081
Closed Access | Times Cited: 3
Inhibiting arachidonic acid generation mitigates aging-induced hyperinsulinemia and insulin resistance in mice
Xiao Xiao, Longxuan Yang, Xiao Lei, et al.
Clinical Nutrition (2024) Vol. 43, Iss. 7, pp. 1725-1735
Closed Access | Times Cited: 3
Advances in the Therapeutic Application of Small-Molecule Inhibitors and Repurposed Drugs against Snakebite
Upasana Puzari, Pedro Alexandrino Fernandes, Ashis K. Mukherjee
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 19, pp. 13938-13979
Closed Access | Times Cited: 20
Action of Varespladib (LY-315920), a Phospholipase A2 Inhibitor, on the Enzymatic, Coagulant and Haemorrhagic Activities of Lachesis muta rhombeata (South-American Bushmaster) Venom
Pamella G. Gutierres, Diego Roberto Pereira, Nataly L. Vieira, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 13
In vivo treatment with varespladib, a phospholipase A2 inhibitor, prevents the peripheral neurotoxicity and systemic disorders induced by Micrurus corallinus (coral snake) venom in rats
Rosimeire Silva-Carvalho, Matheus Z. Gaspar, Luiz H.B. Quadros, et al.
Toxicology Letters (2021) Vol. 356, pp. 54-63
Open Access | Times Cited: 17
Biochemistry and toxicology of proteins and peptides purified from the venom of Vipera berus berus
Jüri Siigur, Ene Siigur
Toxicon X (2022) Vol. 15, pp. 100131-100131
Open Access | Times Cited: 10
Varespladib (LY315920) prevents neuromuscular blockage and myotoxicity induced by crotoxin on mouse neuromuscular preparations
Fernanda Valadares Maciel, Êmylle Karoline Ramos Pinto, Natália Muradas Valério Souza, et al.
Toxicon (2021) Vol. 202, pp. 40-45
Closed Access | Times Cited: 14
Effect of the phospholipase A2 inhibitor Varespladib, and its synergism with crotalic antivenom, on the neuromuscular blockade induced by Crotalus durissus terrificus venom (with and without crotamine) in mouse neuromuscular preparations
Jocimar de Souza, Isadora Caruso Fontana Oliveira, Edson Hideaki Yoshida, et al.
Toxicon (2022) Vol. 214, pp. 54-61
Closed Access | Times Cited: 8
Proteolytic Homeostasis in the Tissue of the Spleen and the Heart of Rats Injected with the Venom of Vipera berus berus and Vipera berus nikolskii
Mariia Palamarchuk, А. М. Bobr, Aleksandr Mudrak, et al.
Current Applied Science and Technology (2023) Vol. 23, Iss. 6
Open Access | Times Cited: 4
Bothrops leucurus snake venom protein profile, isolation and biological characterization of its major toxin PLA2s-like
Êuder Reis Dias, Laudicéia Alves de Oliveira, Pedro Santana Sales Lauria, et al.
Toxicon (2022) Vol. 213, pp. 27-42
Closed Access | Times Cited: 7
Venom protection by broadly neutralizing antibody from a snakebite subject
Jacob Glanville, Joel Christian Andrade, Mark Bellin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 7
A Combined Bioassay and Nanofractionation Approach to Investigate the Anticoagulant Toxins of Mamba and Cobra Venoms and Their Inhibition by Varespladib
Arif Arrahman, Taline D. Kazandjian, Kristina B. M. Still, et al.
Toxins (2022) Vol. 14, Iss. 11, pp. 736-736
Open Access | Times Cited: 7
Considerations for the development of a field-based medical device for the administration of adjunctive therapies for snakebite envenoming
R. Marshall Werner, Allison N. Soffa
Toxicon X (2023) Vol. 20, pp. 100169-100169
Open Access | Times Cited: 3
Cold Finger: Raynaud Phenomenon Following Snakebite Envenoming by Nikolsky’s Viper (Vipera berus nikolskii)
Олександр Зіненко, Daniela M. Durkin, Rebecca W. Carter, et al.
Toxins (2023) Vol. 15, Iss. 10, pp. 598-598
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top